Supernus Pharmaceuticals (SUPN) Stock Forecast
Supernus Pharmaceuticals
AI forecast: SUPN
The AI publishes a target price for the next trading day, the end of the week and the end of the month. The change is measured from the latest price. These are statistical estimates, not investment advice.
Price over the last 6 months
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Forecast track record
The forecast track record — every past forecast next to the actual close — is part of Premium.
Unlock PremiumAbout This Company
Supernus Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and delivers patented medicines for the treatment of central nervous system disorders and diseases, including clinical-stage candidates for neurological and psychiatric conditions such as epilepsy, conductive disorder, Parkinson’s disease, ADHD and depression.
